This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Find out when to change your budget based on your spending habits. Regular adjustments can improve your financial health.
23,632 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
A new, sizable stake in Cal-Maine Foods hints at investor conviction despite a halved income last quarter. This piece...
A new collaboration between Uber and Amazon's Zoox signals more than tech sharing. This alliance could redefine the e...
Institutional investors are eyeing Millrose Properties’ land-banking model as the housing market shifts. This look at...
Intel stunned investors in 2026 with a 225% surge. This guide explores the factors behind that rally and what it coul...
A sweeping 30-point plan reshapes Ireland's crypto rules. Learn what changes mean for investors, firms, and everyday ...
Union electricians rely on a layered, hour-based pension system that can shortchange retirees if filings, vesting, or...
The ethereum staking address holds about half of ETH in circulation, a milestone that highlights how staking and burn...
The Nasdaq Composite steadied amid a breathless week of data, with investors weighing slowing growth against resilien...
Retirees are discovering a niche income strategy that delivers roughly 5% yields with minimal price swings. This arti...
Salesforce unveiled a $50 billion buyback and a new AI metric, but traders remain wary that AI disruption could erode...
A bold claim from Jim Cramer has reignited the debate over Disney buying Norwegian Cruise Line. With shipyard bottlen...